Moreover, PRC1 activity in DNPC leads to the upregulation of CCL2, resulting in bone and visceral metastases, stem cell properties, and the formation of an immunosuppressive tumor microenvironment [132]. This evidence concerns the gene CCL2 and neoplasm.